Patient characteristics
. | NPM1mut relapse . | NPM1wt relapse . | P . |
---|---|---|---|
Total, n | 90 | 14 | |
Sex, n (%) | |||
Female | 52 (58) | 7 (50) | NS |
Male | 38 (42) | 7 (50) | NS |
Age, median (range), y | 59 (22-82) | 62 (41-72) | NS |
AML subtype, n (%) | |||
M0 | 2 (2) | — | NS |
M1 | 36 (40) | 8 (57) | NS |
M2 | 21 (23) | 3 (21) | NS |
M4 | 22 (23) | 2 (14) | NS |
M5a | 1 (6) | 1 (7) | NS |
M5b | 4 (4) | — | NS |
M6 | 1 (1) | — | NS |
Not specified | 4 (4) | — | NS |
Initial blast count in BM, median (range), % | 76 (21-99) | 84 (26-90) | NS |
Leukocyte count, median (range), ×109/L | 30 (1-213) | 3 (0.9-51) | .008 |
Hemoglobin, median (range), g/dL | 9.4 (4-16) | 9.8 (8-13) | NS |
Platelet count, median (range), ×109/L | 66 (9-1100) | 128 (32-267) | .018 |
. | NPM1mut relapse . | NPM1wt relapse . | P . |
---|---|---|---|
Total, n | 90 | 14 | |
Sex, n (%) | |||
Female | 52 (58) | 7 (50) | NS |
Male | 38 (42) | 7 (50) | NS |
Age, median (range), y | 59 (22-82) | 62 (41-72) | NS |
AML subtype, n (%) | |||
M0 | 2 (2) | — | NS |
M1 | 36 (40) | 8 (57) | NS |
M2 | 21 (23) | 3 (21) | NS |
M4 | 22 (23) | 2 (14) | NS |
M5a | 1 (6) | 1 (7) | NS |
M5b | 4 (4) | — | NS |
M6 | 1 (1) | — | NS |
Not specified | 4 (4) | — | NS |
Initial blast count in BM, median (range), % | 76 (21-99) | 84 (26-90) | NS |
Leukocyte count, median (range), ×109/L | 30 (1-213) | 3 (0.9-51) | .008 |
Hemoglobin, median (range), g/dL | 9.4 (4-16) | 9.8 (8-13) | NS |
Platelet count, median (range), ×109/L | 66 (9-1100) | 128 (32-267) | .018 |
BM, bone marrow; NS, not significant.